TECX

Tectonic Therapeutic Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↓ 4/10
  • Value↑ 5/10
Tectonic Therapeutic sales and earnings growth
TECX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 27.36%
  • FCF Y/Y↓ -3.91%
Tectonic Therapeutic gross and profit margin trends
TECX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ -751.10%
Tectonic Therapeutic net debt vs free cash flow
TECX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1611.9

Tectonic Therapeutic stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks